sar
coronaviru
rna
viru
whose
replic
errorpron
provid
possibl
escap
host
defens
even
lead
evolut
new
viral
strain
passag
transmiss
lot
variat
detect
among
differ
sarscov
strain
studi
variat
help
develop
effici
vaccin
moreov
test
nucleic
acid
character
genet
stabil
sarscov
import
research
inactiv
vaccin
whole
genom
sequenc
two
sar
coronaviru
strain
passag
vero
cell
cultur
determin
compar
earli
passag
respect
result
show
sar
coronaviru
strain
high
genet
stabil
although
nearli
gener
pass
four
nucleotid
variat
observ
second
passag
passag
strain
identif
sar
inactiv
vaccin
moreov
one
nucleotid
differ
third
passag
passag
strain
sar
inactiv
vaccin
therefor
studi
suggest
possibl
develop
inactiv
vaccin
sarscov
futur
sever
acut
respiratori
syndrom
sar
first
occur
novemb
guangdong
provinc
china
lifethreaten
respiratori
diseas
juli
world
peopl
infect
peopl
die
mortal
rate
high
accord
http
cmbibjmueducnlcmbidata
sar
caus
pathogen
member
famili
coronavirida
singlestrand
positivesens
rna
genom
sequenc
fulllength
genom
sarscov
kilobas
length
open
read
frame
genom
organ
similar
coronaviru
howev
phylogenet
analys
sequenc
comparison
show
sarscov
close
relat
previous
character
coronaviru
although
number
uniqu
featur
sarscov
close
relat
group
coronaviru
earli
splitoff
group
branch
previou
studi
also
indic
sarscov
resembl
known
coronaviru
includ
lev
beij
isol
epidem
china
j
howev
earli
infect
sarscov
may
origin
wild
anim
scovlik
virus
isol
himalayan
palm
civet
genom
ident
human
isol
sequenc
found
anim
isol
detect
human
isol
studi
also
show
five
strain
human
contain
segment
delet
delet
region
observ
human
isol
anim
isol
sarscoy
like
rna
viru
prone
high
mutat
rate
error
replic
escap
host
defens
base
substitut
identifi
among
sar
isol
chang
amino
acid
sequenc
j
addit
singl
nucleotid
variat
detect
among
sequenc
neutral
mutat
rate
sarscov
similar
known
rna
viru
onethird
human
immunodefici
viru
j
molecular
epidemiolog
approach
sequenc
analysi
sarscov
virus
isol
taiwanes
patient
suggest
recent
introduct
virus
human
popul
estim
genom
mutat
rate
per
genom
demonstr
possibl
one
lowest
rate
among
known
rna
virus
ioj
fulllength
cdna
sarscov
urbani
strain
assembl
molecularli
clone
sar
virus
rescu
use
five
contigu
cdna
fragment
span
entir
genom
recombin
virus
replic
effici
wild
type
viru
fulllength
cdna
sarscov
allow
develop
test
candid
vaccin
especi
develop
live
attenu
vaccin
work
whole
genom
sequenc
two
sarscov
virus
passag
vero
cell
cultur
determin
develop
inactiv
vaccin
materi
method
viru
two
sarscov
strain
obtain
chines
academi
medic
scienc
peke
union
medic
colleg
renam
sinol
strain
strain
sino
biotech
co
ltd
respect
viral
strain
origin
isol
peke
union
hospit
nasal
swab
two
sar
patient
confirm
sarscov
pcr
electron
microscopi
complet
genom
sequenc
submit
genbank
name
strain
strain
respect
studi
strain
genbank
second
passag
sino
strain
isol
strain
genbank
third
passag
strain
isol
sarscov
strain
propag
vero
cell
flask
c
cell
show
cytopath
effect
three
freezethaw
cycl
virus
harvest
well
character
batch
viru
store
c
seed
refer
virus
neutral
assay
vero
cell
obtain
american
type
cultur
collect
atcc
grown
c
minimum
essenti
medium
mem
contain
wv
fetal
calf
serum
glutamin
final
passag
sino
strain
sino
isol
passag
strain
isol
obtain
subsequ
passag
vero
cell
cultur
viru
collect
trizol
ls
reagent
invitrogen
usa
ad
viral
rna
extract
work
finish
biosafeti
level
ii
viral
rna
extract
rtpcr
sampl
remov
viral
genom
rna
extract
condit
random
hexamer
primer
promega
usa
use
cdna
firststrand
synthesi
cdna
firststrand
synthes
specif
primer
pair
use
reaction
pcr
rapid
amplif
cdna
end
race
perform
captur
viral
genom
three
primer
design
race
one
race
two
race
iii
sequenc
analysi
race
product
pcr
product
cut
agaros
gel
purifi
use
geneclean
iii
kit
qbiogen
other
purifi
multiscreenpcr
plate
millipor
pcr
fragment
directli
sequenc
inward
outward
direct
autom
sequenc
bigdy
termin
kit
perkin
elmer
run
abi
dna
sequenc
use
phred
phrap
cons
packag
process
raw
sequenc
read
base
call
assembl
edit
sequenc
region
poor
qualiti
resequenc
purifi
pcr
fragment
align
genom
sequenc
sarscov
perform
clustal
w
line
http
amino
acid
sequenc
seven
protein
also
align
clustal
total
isol
fragment
obtain
rtpcr
race
span
entir
genom
compon
sequenc
determin
duplic
averag
length
base
therefor
region
genom
fourfold
sixfold
coverag
bp
everi
overlap
final
complet
genom
sequenc
assembl
genom
passag
strain
isol
genbank
nucleotid
length
passag
sino
strain
sino
isol
genbank
bp
compar
isol
genbank
nucleotid
delet
kept
viral
strain
passag
cell
cultur
delet
strain
delet
sinol
strain
respect
comparison
genom
sequenc
align
fulllength
genom
sarscov
isol
finish
isol
isol
found
delet
end
genom
compar
three
sarscov
isol
sinoll
isol
isol
except
delet
delet
insert
detect
earli
passag
late
passag
two
viru
strain
think
isol
genom
could
captur
complet
addit
four
singl
nucleotid
variat
detect
second
passag
passag
sino
strain
strain
genom
differ
one
nucleotid
revers
nucleotid
posit
g
sinoll
isol
might
result
backmut
event
occur
potenti
passag
viru
studi
also
show
exist
genet
variat
primari
sampl
virus
isol
limit
passag
cultur
two
sar
patient
two
sequenc
patient
complet
ident
singl
nucleotid
variat
detect
two
sequenc
hand
less
variat
observ
transmiss
sar
genom
sequenc
viral
isol
five
amoy
garden
patient
finish
viru
sequenc
ident
four
five
patient
two
singl
nucleotid
variat
exist
sequenc
patient
howev
studi
five
sar
isol
index
patient
three
primari
contact
index
patient
one
secondari
contact
relat
index
patient
suggest
mutat
occur
transmiss
escap
host
immun
respons
two
sequenc
primari
contact
found
delet
delet
noncod
region
respect
besid
delet
nucleotid
substitut
among
five
sequenc
viru
passag
cell
cultur
fewer
mutat
transmiss
stabl
condit
cell
cultur
nonselect
pressur
host
mutat
point
viral
genom
low
similar
result
variat
orflab
n
studi
four
five
singl
nucleotid
variat
found
region
encod
pplab
contain
length
whole
genom
remaind
region
encod
glycoprotein
ii
comparison
amino
acid
sequenc
major
protein
align
amino
acid
sequenc
seven
major
protein
pplab
e
n
perform
variat
found
pplab
e
lfor
none
n
respect
variat
glycoprotein
e
protein
protein
shown
fig
among
five
amino
acid
variat
polyprotein
three
locat
orfla
other
lay
orflb
far
glycoprotein
concern
amino
acid
sequenc
subunit
variabl
subunit
variat
detect
align
differ
sequenc
indic
amino
acid
mutat
glycoprotein
locat
sl
subunit
studi
also
found
amino
acid
variat
glycoprotein
lay
domain
addit
delet
sinol
strain
genom
caus
amino
acid
delet
e
protein
delet
strain
genom
region
encod
protein
caus
stop
translat
delet
occur
region
appar
effect
surviv
viru
suggest
region
either
noncod
code
function
unimport
put
protein
hand
five
base
substitut
passag
viru
cell
cultur
also
chang
amino
acid
sequenc
also
show
rate
nonsynonym
chang
greater
synonym
chang
gene
sequenc
orfla
sequenc
io
j
although
amino
acid
sequenc
two
sarscov
isol
chang
passag
sign
show
remark
chang
immunogen
antigen
viral
titer
level
passag
sarscov
passag
cell
cultur
high
stabil
number
variat
found
among
separ
sarscov
virus
studi
mutat
help
develop
effect
safe
vaccin
j
moreov
low
mutat
rate
sarscov
suggest
develop
vaccin
sarscov
futur
would
less
difficult
expect
io
j
addit
studi
strain
use
develop
inactiv
vaccin
sino
strain
use
test
candid
vaccin
import
know
genet
stabil
complet
genom
two
sarscov
isol
repassag
vera
cell
cultur
sequenc
analyz
result
indic
high
genet
stabil
sarscov
passag
vera
cell
cultur
impli
high
possibl
develop
inactiv
vaccin
sarscov
